TITLE

Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins

AUTHOR(S)
Au, Sandy; Ng, Irene; Wong, Chun-Ming
PUB. DATE
June 2013
SOURCE
Frontiers of Medicine;Jun2013, Vol. 7 Issue 2, p231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88060322

 

Related Articles

  • Polycomb Repressive Complex 2 (PRC2) Restricts Hematopoietic Stem Cell Activity. Majewski, Ian J.; Blewitt, Marnie E.; de Graaf, Carolyn A.; McManus, Edward J.; Bahlo, Melanie; Hilton, Adrienne A.; Hyland, Craig D.; Smyth, Gordon K.; Corbin, Jason E.; Metcalf, Donald; Alexander, Warren S.; Hilton, Douglas J. // PLoS Biology;Apr2008, Vol. 6 Issue 4, pe93 

    Epigenetic modifications are central to the maintenance of cellular identity and are dynamically regulated during differentiation. We addressed the role of Polycomb group proteins during hematopoiesis and define a series of genes that are highly responsive to Polycomb dysfunction.

  • Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.  // British Medical Journal;9/3/1977, Vol. 2 Issue 6087, p611 

    Focuses on the excessive alpha-fetoprotein concentrations in hepatocellular carcinoma. Description of a patient with hepatocellular carcinoma; History of the patient's disease; Presentation of protein diagram.

  • From the editors.  // Nature Reviews Cancer;Nov2009, Vol. 9 Issue 11, p763 

    The article discusses various reports published within the issue including the review about the regulation of the cell cycle, one on epigenetics and genetics of cancer, and one on the polycomb group (PcG) proteins.

  • Transcriptional regulation by Polycomb group proteins. Di Croce, Luciano; Helin, Kristian // Nature Structural & Molecular Biology;Oct2013, Vol. 20 Issue 10, p1147 

    Polycomb group (PcG) proteins are epigenetic regulators of transcription that have key roles in stem-cell identity, differentiation and disease. Mechanistically, they function within multiprotein complexes, called Polycomb repressive complexes (PRCs), which modify histones (and other proteins)...

  • Hepatocellular Carcinoma. Di Bisceglie, Adrian M.; Rustgi, Vinod K.; Hoofnagle, Jay H.; Dusheiko, Geoffrey M.; Lotze, Michael T. // Annals of Internal Medicine;Mar88, Vol. 108 Issue 3, p390 

    Focuses on hepatocellular carcinoma. Nature of hepatocellular carcinoma; Role of hepatitis B virus infection in the etiology of hepatocellular carcinoma; Epidemiology of hepatocellular carcinoma; Diagnosis and treatment of hepatocellular carcinoma.

  • Cancer epigenetics: linking basic biology to clinical medicine. Hsing-Chen Tsai; Baylin, Stephen B. // Cell Research;Mar2011, Vol. 21 Issue 3, p502 

    Cancer evolution at all stages is driven by both epigenetic abnormalities as well as genetic alterations. Dysregulation of epigenetic control events may lead to abnormal patterns of DNA methylation and chromatin configurations, both of which are critical contributors to the pathogenesis of...

  • Genetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma. Shu-Bin Gao; Shi-Long Sun; Qi-Lin Zheng; Li Zhang; Yuequan Zhu; Guang-Hui Jin; Li-Xiang Xue // American Journal of Cancer Research;2015, Vol. 5 Issue 10, following p2969 

    Although the abnormal expression of Polycomb-group (PcG) proteins is closely associated with carcinogenesis and the clinicopathological features of hepatocellular carcinoma (HCC), the genetic mutation profile of PcG genes has not been well established. In this study of human HCC specimens, we...

  • Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma. Kgatle, Mankgopo M.; Setshedi, Mashiko; Hairwadzi, Henry N. // BioMed Research International;12/26/2016, Vol. 2016, p1 

    Hepatocellular carcinoma (HCC) is a major public health concern and one of the leading causes of tumour-related deaths worldwide. Extensive evidence endorses that HCC is a multifactorial disease characterised by hepatic cirrhosis mostly associated with chronic inflammation and hepatitis B/C...

  • Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice. Shibo Qi; Bin Li; Tan Yang; Yong Liu; Shanshan Cao; Xingxing He; Peng Zhang; Lei Li; Chuanrui Xu // International Journal of Molecular Sciences;2014, Vol. 15 Issue 11, p20004 

    Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of various cancers and governs the self-renewal of multiple types of stem cells. Our previous studies have revealed that Bmi1 acts as an oncogene in hepatic carcinogenesis in an INK4a/ARF locus...

  • Epigenetic Events in Liver Cancer Resulting From Alcoholic Liver Disease. French, Samuel W. // Alcohol Research: Current Reviews;2013, Vol. 4 Issue 1, p57 

    Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma [HCC]) associated with alcoholic liver disease (ALD) as well as in liver disease associated with other conditions. For example, epigenetic mechanisms, such as changes in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics